Provided by Tiger Trade Technology Pte. Ltd.

Capricor Therapeutics

6.29
-0.5450-7.97%
Post-market: 6.380.0900+1.43%19:59 EDT
Volume:8.36M
Turnover:53.59M
Market Cap:365.69M
PE:-2.55
High:7.08
Open:6.81
Low:6.01
Close:6.84
52wk High:40.37
52wk Low:2.96
Shares:58.14M
Float Shares:45.54M
Volume Ratio:0.38
T/O Rate:18.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4659
EPS(LYR):-2.2601
ROE:-73.70%
ROA:-33.63%
PB:1.49
PE(LYR):-2.78

Loading ...

Kaos Capital urges Capricor shareholders to support immediate board meeting

TIPRANKS
·
Aug 21

Kaos Capital : Plans to Nominate Two Independent Director Candidates at Capricor & to Seek Board-Led M&a and Strategic Alternatives Committee

THOMSON REUTERS
·
Aug 21

Kaos Capital: Demands an Immediate Meeting, Board Change, and Capital-Preservation Plan at Capricor

THOMSON REUTERS
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Aug 16

Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval

Benzinga Earnings
·
Aug 14

Sector Update: Healthcare Stocks Flat to Lower Pre-Bell Friday

MT Newswires Live
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Aug 14

U.S. Stocks on the MOVE-Reddit, Capricor Therapeutics, Birkenstock

Reuters
·
Aug 14

Cantor Fitzgerald Upgrades Capricor Therapeutics to Overweight From Neutral, Adjusts PT to $28 From $3.50

MT Newswires Live
·
Aug 14

Top Premarket Gainers

MT Newswires Live
·
Aug 14

Capricor Shares Skyrocket as FDA Agrees to Review New Duchenne Drug Data

Reuters
·
Aug 14

Capricor Therapeutics Shares up 105.9% Premarket After FDA Agrees to Review New Duchenne Drug Data

THOMSON REUTERS
·
Aug 14

Capricor Therapeutics Raised to Overweight from Neutral by Cantor Fitzgerald

Dow Jones
·
Aug 14

Capricor Therapeutics (CAPR) Shares Soar Over 67% After Hours: Here's Why

Benzinga Earnings
·
Aug 14

Capricor Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Capricor Therapeutics Q2 EPS $(0.70) Misses $(0.58) Estimate

Benzinga Earnings
·
Aug 14

Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 14

U.S. Earnings Preview: After Market Close Aug. 13

Dow Jones
·
Aug 14

Capricor Therapeutics Lawsuit Focuses on Deramiocel Disclosures After CAPR Stock Drops

TIPRANKS
·
Aug 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13